![Andrew Bishop](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Bishop
Finanzdirektor/CFO bei
ARCH BIOPARTNERS INC.
Vermögen: 247 260 $ am 31.05.2026
Profil
Andrew Bishop is Chief Financial Officer & Executive Director at Arch Biopartners, Inc. since 2010.
Mr. Bishop is Principal at Bingley Capital, Inc. since 2009.
Former roles include Independent Director at Liminal BioSciences, Inc., Director at Willow Breast & Hereditary Cancer Support, Director at AmacaThera, Inc., Principal at Gordon Capital Corp., Principal at HSBC Securities (Canada), Inc., and Principal at First Marathon Securities Ltd. Education includes undergraduate studies at McGill University and an MBA from The Schulich School of Business, conferred in 1993.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.11.2025 | 780’000 ( 1.15% ) | 247 260 $ | 31.05.2026 |
Aktive Positionen von Andrew Bishop
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCH BIOPARTNERS INC. | Finanzdirektor/CFO | 01.04.2010 |
Bingley Capital, Inc.
 Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Private Equity Investor | 01.01.2009 |
Ehemalige bekannte Positionen von Andrew Bishop
| Unternehmen | Position | Ende |
|---|---|---|
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Direktor/Vorstandsmitglied | - |
Willow Breast & Hereditary Cancer Support | Vorsitzender | - |
Gordon Capital Corp.
 Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Corporate Officer/Principal | - |
HSBC Securities (Canada), Inc.
 HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
First Marathon Securities Ltd.
 First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Corporate Officer/Principal | - |
Ausbildung von Andrew Bishop
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
22
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Gordon Capital Corp.
Gordon Capital Corp. Investment Banks/BrokersFinance Provides investing banking services | Finance |
HSBC Securities (Canada), Inc.
HSBC Securities (Canada), Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
First Marathon Securities Ltd.
First Marathon Securities Ltd. Investment Banks/BrokersFinance Provides security brokerage and flotation services | Finance |
Arch Biopartners, Inc.
 Arch Biopartners, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops novel drugs | Health Technology |
The Schulich School of Business
 The Schulich School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bingley Capital, Inc.
Bingley Capital, Inc. Investment ManagersFinance Bingley Capital invests in small and medium scale companies with EBITDA of at least $2 million and sales of $10 to $100 million. The firm targets companies in the fields of industrial and Consumer Products. They do not invest in retailing, real estate, mining, oil & gas and technology-based companies. Bingley acquires controlling interests and provides financing in the form of equity & debt for buyout, MBO and growth capital requirements. | Finance |
Willow Breast & Hereditary Cancer Support | |
AmacaThera, Inc.
AmacaThera, Inc. Medical SpecialtiesHealth Technology Engages in developing and commercializing of injectable hydrogel platform technology for a wide range of medical applications | Health Technology |
